In Press,
Cerebral Cortex
Underconnectivity
in autism
3al. 1995) implicated lower inter-regional brainconnectivity in autism.In fMRI studies, functional connectivitymeasurements are based on the correlation of theactivation time-series in pairs of brain areas. The timeseries in this study included an observation every 3sec (i.e. a TR of 3 sec) while participants wereperforming the TOL task. The general assumption isthat the functioning of voxels whose activation levelsrise and fall together is coordinated. The functionalconnectivity was measured between some of the keyareas involved in executive processing, and then wascompared between the autism and controlparticipants. The main hypothesis was that therewould be a lower level of functional connectivityamong the autism participants in the frontal-parietalnetwork.The functional connectivity in the TOL task,which is known to engage prefrontal and parietalareas bilaterally (Newman et al., 2003), might welldepend on the corpus callosum as part of thebiological infrastructure that permits communicationamong brain areas. This study measured the size of the various segments of the corpus callosum of eachparticipant in the functional imaging study,hypothesizing that the sizes of key areas would besmaller in the autistic participants, following similarprevious findings in purely morphometric studies(Egaas et al., 1995; Hardan et al., 2000; Piven et al.,1997). Moreover, for the first time, this study testsfor a correlation between the size of various corpuscallosum segments and frontal-parietal functionalconnectivity. The secondary hypothesis was that inthe participants with autism, there would be apositive correlation, because the size of the corpuscallosum is constraining the functional connectivity.In the control group, there should be no correlationbecause there is no constraint on informationprocessing imposed by the size of their corpuscallosum and their neural connectivity. That is, theirneural resources and neural connectivity are assumedto always be adequate to meet these task demands.
Methods
Participants.
Eighteen high-functioningindividuals with autism (mean age 27.1 years, SD =11.9) and eighteen healthy participants (mean age24.5 years, SD = 9.9) were included in the study (FullScale and Verbal IQ scores of 80 or above, as shownin Table 1. The diagnosis of autism was establishedusing the ADI-R (Autism Diagnostic Interview-Revised, Lord et al., 1994), the ADOS-G (AutismDiagnostic Observation Schedule-General, Lord et al.,2000), and confirmed by expert clinical diagnosis. Nineof the participants with autism were taking psychotropicmedications. Of these, six were taking only onemedication, a serotonin reuptake inhibitor, but not on theday of the scan. All participants were required to be ingood medical health. Potential autistic participants wereexcluded if they had evidence of an associatedinfectious, genetic, or metabolic disorder, such asfragile-X syndrome or tuberous sclerosis. Potentialcontrol and autistic participants were also excluded if found to have evidence of birth asphyxia, head injury, ora seizure disorder. Exclusions were based on neurologichistory and examination, physical examination, andchromosomal analysis or metabolic testing if indicated.Written informed consent was obtained from participantsand/or their guardians, using procedures approved by theUniversity of Pittsburgh Medical Center InstitutionalReview Board.The control participants were communityvolunteers recruited to match the autistic participants onage, Full Scale IQ, gender, race, and family of originsocioeconomic status, as measured by the Hollingsheadmethod (Hollingshead, 1957). Potential controlparticipants were screened by questionnaire, telephone,face-to-face interview, and observation during screeningpsychometric tests such as the Wechsler AbbreviatedScales of Intelligence (WASI) (Wechsler, 1999) and TheWide Range Achievement Test 3 (WRAT3). Familyhistory of developmental and neuropsychiatric disorderswas obtained using a questionnaire specificallydeveloped for the CPEA research program. Exclusionarycriteria, evaluated through these procedures, includedcurrent or past history of psychiatric and neurologicdisorders, birth injury, developmental delay, schoolproblems, acquired brain injury, learning disabilities,and medical disorders with implications for the centralnervous system or those requiring regular medicationusage. Potential control participants were also screenedto exclude those with a family history of autism,developmental cognitive disorder, learning disability,affective disorder, anxiety disorder, schizophrenia,obsessive compulsive disorder, or other neurologic orpsychiatric disorder thought to have a geneticcomponent. There were no statistically reliabledifferences between the autistic and control participantsin age or IQ. All participants were Caucasian. Twelve of the participants with autism and 9 control participantswere previously included in a study of functionalconnectivity in a sentence comprehension task (Just etal., 2004), and one participant with autism waspreviously included in a study of functional connectivityin a verbal working memory task (Koshino et al., 2005).
Add a Comment